Literature DB >> 14574645

A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Matthew Stephens1, Peter Donnelly.   

Abstract

In this report, we compare and contrast three previously published Bayesian methods for inferring haplotypes from genotype data in a population sample. We review the methods, emphasizing the differences between them in terms of both the models ("priors") they use and the computational strategies they employ. We introduce a new algorithm that combines the modeling strategy of one method with the computational strategies of another. In comparisons using real and simulated data, this new algorithm outperforms all three existing methods. The new algorithm is included in the software package PHASE, version 2.0, available online (http://www.stat.washington.edu/stephens/software.html).

Mesh:

Year:  2003        PMID: 14574645      PMCID: PMC1180495          DOI: 10.1086/379378

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms.

Authors:  Tianhua Niu; Zhaohui S Qin; Xiping Xu; Jun S Liu
Journal:  Am J Hum Genet       Date:  2001-11-26       Impact factor: 11.025

3.  Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms.

Authors:  Zhaohui S Qin; Tianhua Niu; Jun S Liu
Journal:  Am J Hum Genet       Date:  2002-11       Impact factor: 11.025

4.  Haplotype inference in random population samples.

Authors:  Shin Lin; David J Cutler; Michael E Zwick; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2002-10-17       Impact factor: 11.025

Review 5.  Inference of haplotypes from PCR-amplified samples of diploid populations.

Authors:  A G Clark
Journal:  Mol Biol Evol       Date:  1990-03       Impact factor: 16.240

6.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.

Authors:  L Excoffier; M Slatkin
Journal:  Mol Biol Evol       Date:  1995-09       Impact factor: 16.240

8.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

Authors:  C M Drysdale; D W McGraw; C B Stack; J C Stephens; R S Judson; K Nandabalan; K Arnold; G Ruano; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

9.  Sequence variation in the human angiotensin converting enzyme.

Authors:  M J Rieder; S L Taylor; A G Clark; D A Nickerson
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

  9 in total
  1127 in total

1.  Analytical methods for immunogenetic population data.

Authors:  Steven J Mack; Pierre-Antoine Gourraud; Richard M Single; Glenys Thomson; Jill A Hollenbach
Journal:  Methods Mol Biol       Date:  2012

2.  Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.

Authors:  L Gineau; P Luisi; E C Castelli; J Milet; D Courtin; N Cagnin; B Patillon; H Laayouni; P Moreau; E A Donadi; A Garcia; A Sabbagh
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

3.  Ancient founder mutation is responsible for Imerslund-Gräsbeck Syndrome among diverse ethnicities.

Authors:  Cameron M Beech; Sandya Liyanarachchi; Nidhi P Shah; Amy C Sturm; May F Sadiq; Albert de la Chapelle; Stephan M Tanner
Journal:  Orphanet J Rare Dis       Date:  2011-11-13       Impact factor: 4.123

4.  An efficient study design to test parent-of-origin effects in family trios.

Authors:  Xiaobo Yu; Gao Chen; Rui Feng
Journal:  Genet Epidemiol       Date:  2017-07-20       Impact factor: 2.135

5.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

6.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

7.  Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens.

Authors:  Eric Lévesque; Anne-Sophie Bélanger; Mario Harvey; Félix Couture; Derek Jonker; Federico Innocenti; Erica Cecchin; Giuseppe Toffoli; Chantal Guillemette
Journal:  J Pharmacol Exp Ther       Date:  2013-02-05       Impact factor: 4.030

8.  Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry.

Authors:  Vincent Bekker; Thomas R O'Brien; Stephen Chanock
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

9.  Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk.

Authors:  Brian L Yaspan; Joan P Breyer; Qiuyin Cai; Qi Dai; J Bradford Elmore; Isaac Amundson; Kevin M Bradley; Xiao-Ou Shu; Yu-Tang Gao; William D Dupont; Wei Zheng; Jeffrey R Smith
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

10.  Impact of interacting functional variants in COMT on regional gray matter volume in human brain.

Authors:  Robyn Honea; Beth A Verchinski; Lukas Pezawas; Bhaskar S Kolachana; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Neuroimage       Date:  2008-11-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.